Scientz TDS-1012 Automated Transdermal Diffusion Sampling System
| Brand | Scientz |
|---|---|
| Origin | Zhejiang, China |
| Manufacturer Type | Original Equipment Manufacturer (OEM) |
| Product Origin | Domestic (China) |
| Model | TDS-1012 |
| Pricing | Upon Request |
Overview
The Scientz TDS-1012 Automated Transdermal Diffusion Sampling System is an engineered platform for standardized in vitro release testing (IVRT) and in vitro permeation testing (IVPT) of semisolid dermatological formulations. It operates on the Franz diffusion cell principle—utilizing static or dynamic membrane diffusion under controlled thermal and mechanical conditions to quantify drug release kinetics and transdermal flux across synthetic or biological membranes. Designed in strict alignment with United States Pharmacopeia (USP) “Drug Release Testing for Topical Semisolid Dosage Forms”, the system supports regulatory-compliant method development, formulation optimization, and quality-by-design (QbD) workflows in pharmaceutical R&D, QC laboratories, and contract research organizations (CROs).
Key Features
- Glass Franz diffusion cells compliant with USP geometry, thermal conductivity, and dimensional tolerances
- Automated air bubble removal mechanism ensuring continuous, unbroken contact between membrane and receptor medium
- Dry-block heating system with ±0.2 °C temperature stability across operating range (25–45 °C)
- Dual 6-cell configuration enabling parallel testing of test and reference products under independent thermal and agitation conditions
- Interchangeable quantitative dosing rings (1 mm, 2 mm, 3 mm, and 5 mm internal diameters) for precise application area control
- Modular stirrer assemblies compatible with variable receptor volumes (typically 2.5–7.0 mL), supporting both standard and miniaturized diffusion setups
- Evaporation-suppression dual-layer enclosure: integrated vapor barrier cap + insulated protective hood minimizing solvent loss (<2% volume change over 24 h at 32 °C)
- Ergonomic 10-inch capacitive touchscreen interface with adjustable tilt angle (0–60°) for seated or standing operation
Sample Compatibility & Compliance
The TDS-1012 accommodates a broad spectrum of semisolid dosage forms—including ointments, creams, gels, pastes, and patches—applied onto commercially available synthetic membranes (e.g., Strat-M®, Cellulose acetate) or excised human/porcine skin. All hardware components are constructed from borosilicate glass, PTFE, and 316 stainless steel to ensure chemical inertness and cleanability. The system meets essential design criteria referenced in ICH Q5A(R2), ISO 10993-12, and ASTM E2886–13 for IVRT/IVPT instrumentation. When operated with validated protocols, data generated are suitable for submission to FDA, EMA, and PMDA in support of ANDA, NDA, or generic product dossier filings.
Software & Data Management
The embedded control software enables fully automated, audit-ready operation under 21 CFR Part 11–compliant architecture. Core capabilities include: electronic logbook with time-stamped event recording (method execution, parameter changes, maintenance alerts); hierarchical user access control (four-tier permission levels: Guest, Operator, Supervisor, Administrator); tamper-evident audit trails for all critical actions; export of raw concentration-time datasets in CSV and Excel formats; and cross-device method synchronization via USB or network transfer. No paper-based recordkeeping is required—full traceability is maintained from sample loading through final data export, satisfying GLP and GMP documentation requirements.
Applications
- Comparative IVRT studies for bioequivalence assessment of generic topical products
- Formulation screening of penetration enhancers, viscosity modifiers, and emulsifier systems
- Stability-indicating release profiling under accelerated and real-time storage conditions
- Permeation kinetics modeling (Jss, Kp, lag time) using nonlinear regression analysis
- Supporting Q3 (qualitative/quantitative composition) and Q5 (impurity profile) assessments per ICH guidelines
- Method validation per ICH Q2(R2) for specificity, linearity, accuracy, precision, and robustness
FAQ
Does the TDS-1012 support both IVRT and IVPT protocols simultaneously?
Yes—the dual 6-cell architecture allows concurrent execution of IVRT (membrane-free, donor compartment only) and IVPT (membrane-integrated) configurations within a single run.
Is the system compatible with third-party analytical instruments (e.g., HPLC, UV-Vis)?
All sampling ports conform to standard Luer-lock or septum-piercing interfaces; integration with autosamplers or fraction collectors is achieved via optional tubing kits and timing triggers.
Can the software generate reports compliant with regulatory submission standards?
Yes—predefined report templates include metadata, instrument calibration history, method parameters, raw concentration-time points, and statistical summaries aligned with FDA CDER guidance on topical product development.
What maintenance procedures are required for long-term operational reliability?
Daily cleaning of glass cells and stirrers with ethanol/water; quarterly verification of temperature uniformity and stir speed accuracy using NIST-traceable probes; annual recalibration of heating block and touch interface by authorized service engineers.
